Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 AUD | 0.00% | +4.69% | +63.41% |
05-01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
04-22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+63.41% | 121M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Regulatory Nod to Conduct Kidney Disease Drug Trial in Malaysia